Portfolio company
Sampling Human
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops single-cell analysis platforms and biocytometry kits for diagnostic, healthcare, and research organisations to improve early disease detection and treatment monitoring.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Smartcatch
This company develops microtechnology devices for isolating circulating tumour cells from blood samples to assist researchers and clinicians in cancer diagnosis and monitoring.
Spectacell
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
1Cell.Ai
The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
CS Genetics
This company develops instrument-free single-cell genomics kits for academic researchers and biopharmaceutical organisations to perform transcriptomics without expensive hardware.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
